Endothelial deletion of hyaluronan synthase 2 (Has2) in mice is associated with mesangiolysis, glomerular capillary rarefaction, glomerulosclerosis and albuminuria, findings with direct implications in several disease models, including diabetic nephropathy [57]. This evidence concerns the gene HAS2 and glomerulosclerosis.